MarketFriction

Novateor Research Laboratories Ltd

BSE 542771 · Personal Care
₹37.50 +6.84%
BSE close2026-09-28
Market cap₹22.7 Cr.
P/E227

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales0.070.120.280.460.820.440.360.850.791.982.471.36
Expenses0.160.360.350.571.010.580.531.000.902.002.591.35
Operating Profit-0.09-0.24-0.07-0.11-0.19-0.14-0.17-0.15-0.11-0.02-0.120.01
OPM %-128.57%-200.00%-25.00%-23.91%-23.17%-31.82%-47.22%-17.65%-13.92%-1.01%-4.86%0.74%
Other Income0.000.44-0.210.220.240.250.240.240.240.240.250.24
Interest0.000.000.000.000.000.030.020.010.020.050.050.04
Depreciation0.050.050.050.040.040.040.040.040.060.100.090.09
Profit before tax-0.140.15-0.330.070.010.040.010.040.050.07-0.010.12
Tax %0.00%0.00%0.00%-42.86%0.00%0.00%0.00%0.00%20.00%28.57%100.00%8.33%
Net Profit-0.130.15-0.330.100.010.030.010.040.030.05-0.020.12
EPS in Rs-0.270.31-0.680.210.020.060.020.080.060.10-0.030.20
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales0.020.100.140.090.410.390.190.741.261.212.783.83
Expenses0.020.110.080.040.130.530.520.921.601.542.923.93
Operating Profit0.00-0.010.060.050.28-0.14-0.33-0.18-0.34-0.33-0.14-0.10
OPM %0.00%-10.00%42.86%55.56%68.29%-35.90%-173.68%-24.32%-26.98%-27.27%-5.04%-2.61%
Other Income0.000.010.020.030.110.270.440.010.490.490.480.49
Interest0.000.000.010.010.000.010.000.000.020.030.070.09
Depreciation0.000.000.070.070.100.100.100.090.090.080.160.19
Profit before tax0.000.000.000.000.290.020.01-0.260.040.050.110.11
Tax %24.14%150.00%0.00%-11.54%0.00%40.00%27.27%18.18%
Net Profit0.000.000.000.000.22-0.010.01-0.230.040.030.080.10
EPS in Rs0.000.000.000.000.74-0.020.02-0.480.080.060.170.17
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth44%82%45%38%
Compounded Profit Growth%58%36%25%
Stock Price CAGR%24%5%53%
Return on Equity1%1%1%1%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.050.050.050.052.964.834.834.834.834.834.836.05
Reserves0.880.880.880.881.113.733.743.013.043.935.715.45
Borrowings0.750.760.870.820.010.000.240.240.841.110.911.03
Other Liabilities0.110.150.100.090.240.230.170.060.240.591.161.74
Total Liabilities1.791.841.901.844.328.798.988.148.9510.4612.6114.27
Fixed Assets1.591.641.661.593.553.453.361.941.782.433.413.24
CWIP0.000.000.000.000.000.000.000.000.430.440.000.00
Investments0.010.010.010.010.010.010.010.010.010.010.010.01
Other Assets0.190.190.230.240.765.335.616.196.737.589.1911.02
Total Assets1.791.841.901.844.328.798.988.148.9510.4612.6114.27
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity0.000.000.010.05-0.07-3.42-0.27-0.97-0.97-0.98-1.03-0.18
Cash from Investing Activity0.000.00-0.010.00-1.96-0.10-0.090.910.13-0.25-0.22-0.50
Cash from Financing Activity0.000.000.00-0.032.034.180.32-0.130.581.101.430.89
Net Cash Flow0.000.00-0.010.020.000.67-0.04-0.18-0.26-0.130.180.20
Free Cash Flow0.000.000.000.05-2.03-3.52-0.36-0.06-1.33-1.72-1.73-0.20
CFO/OP0%17%100%0%2,443%82%539%285%297%736%180%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days365.00219.00182.50243.33133.54233.97384.21212.09202.78337.85271.78268.75
Inventory Days4,380.00438.001,460.002,737.506,448.33700.80851.67344.34215.16268.95151.10152.08
Days Payable1,460.00292.00730.001,095.001,460.0014.60104.2920.6661.47207.47176.61208.57
Cash Conversion Cycle3,285.00365.00912.501,885.835,121.87920.171,131.59535.77356.46399.32246.27212.26
Working Capital Days1,277.50109.50286.79527.22462.934,117.959,067.372,747.361,604.841,879.30950.58770.98
ROCE %0.00%0.00%0.57%0.56%9.95%0.47%0.12%2.49%0.71%0.86%1.69%1.67%
Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025May 2025Sep 2025Mar 2026
Promoters60.87%60.87%60.87%60.87%60.87%60.87%60.87%60.87%60.87%51.60%50.90%50.75%
Public39.13%39.13%39.13%39.13%39.13%39.13%39.13%39.12%39.13%48.40%49.09%49.24%
No. of Shareholders164146138118113118122160142164172172

Fundamentals

Market Cap₹ 22.7 Cr.
Current Price₹ 37.5
Stock P/E227
Book Value₹ 19.0
ROCE1.67 %
ROE0.91 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)38%
Compounded Profit Growth (TTM)25%
Standalone figures.
Valuation
Market capRs 23 Cr
Enterprise valueRs 23 Cr
P/E (TTM)226.96x
Price to book1.97x
Price to sales5.93x
EV / EBITDA59.63x
EV / EBIT116.28x
EV / sales6.07x
Earnings yield0.44%
P/E, 3-year average363.43x
P/B, 3-year average1.88x
P/E, 5-year average328.46x
P/B, 5-year average1.46x
Profitability
Operating margin (excl. other income)-2.61%
Operating margin (incl. other income)10.18%
EBITDA margin10.18%
Pre-tax margin2.87%
Net profit margin2.61%
ROE0.91%
ROCE1.67%
ROA0.74%
ROE, 3-year average0.70%
ROCE, 3-year average1.41%
ROA, 3-year average0.58%
ROE, 5-year average-0.04%
ROCE, 5-year average0.37%
ROA, 5-year average-0.09%
ROIC (approx.)1.36%
Tax rate18.18%
Other income / net worth4.26%
Growth
Sales growth (latest year)37.77%
Profit growth (latest year)25.00%
Sales CAGR, 3 years44.86%
Sales CAGR, 5 years82.34%
Profit CAGR, 3 years35.72%
Profit CAGR, 5 years58.49%
Per share
EPS (TTM)Rs 0.17
EPS (latest year)Rs 0.17
EPS, 3-year averageRs 0.13
EPS, 5-year averageRs -0.00
Book value per shareRs 19.00
Sales per shareRs 6.33
Cash flow per shareRs -0.30
Free cash flow per shareRs -0.33
Efficiency
Asset turnover0.27x
Fixed asset turnover1.18x
Inventory turnover2.40x
Inventory days152 days
Debtor days269 days
Debtors turnover1.36x
Creditor days209 days
Cash conversion cycle212 days
Working capital days771 days
Leverage
Total debtRs 1 Cr
Cash and bankRs 0 Cr
Net debtRs 1 Cr
Debt to equity0.09x
Net debt / EBITDA1.44x
Interest coverage2.22x
Owners' fund to total sources80.59%
Debt to assets7.22%
Cash flow
Cash from Operating Activity (latest year)Rs -0 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs 1 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -0 Cr
FCFE (approx.: FCF + change in debt)Rs -0 Cr
Cash from ops / profit, 5 years-206.50x
Statement figures
Net sales (TTM)Rs 4 Cr
Net sales (latest year)Rs 4 Cr
Operating profit excl. other income (latest year)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 0 Cr
PBDT (TTM)Rs 0 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 3 Cr
Total expenditure (latest year)Rs 4 Cr
Total income (latest year)Rs 4 Cr
Share capitalRs 6 Cr
ReservesRs 5 Cr
Shareholders' fundsRs 12 Cr
Total assetsRs 14 Cr
Net blockRs 3 Cr
InvestmentsRs 0 Cr
ReceivablesRs 3 Cr
InventoryRs 1 Cr
Other liabilitiesRs 2 Cr
Shares outstanding (crore)0.61
Ownership
Promoter holding50.75% (-10.12 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 227.0 is at the 54th percentile of its own 2.0-year range (median 193.7, low 17.6, high 391.6).
P/B 1.97 is at the 64th percentile (median 1.49).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period542771Nifty 50Difference
1 week+15.7%-2.8% +18.5 pts
3 years+17.2%+14.2% +3.0 pts
5 years+410.2%+27.9% +382.3 pts

Red flags

F-score 4 of 8
explainWeak cash conversion Cash from operations was -1043% of net profit over the last 3 years
explainShare dilution Share count up 27% in a year, 27% in three
lookProfit leans on other income Other income was 445% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Mar 2026
Sales ₹1 Cr +60.0% vs Mar 2024. Net profit ₹0 Cr +200.0%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Godrej Consumer Products Ltd87,49342.118.8 %
Dabur India Ltd67,48134.020.3 %
Colgate-Palmolive (India) Ltd48,55235.5108 %
Cupid Ltd38,72628233.9 %
Gillette India Ltd22,69434.090.7 %
Procter & Gamble Hygiene and Health Care Ltd22,30528.2157 %
Emami Ltd16,63322.028.1 %
Honasa Consumer Ltd14,39957.019.2 %
Bajaj Consumer Care Ltd6,43928.930.0 %
Anondita Medicare Ltd2,08562.343.8 %
Recode Studios Ltd45440.574.1 %
Radix Industries (India) Ltd20369.219.6 %
Macobs Technologies Ltd18965.311.0 %
H. R. Hygiene Products Ltd15613.730.4 %
Thrive Future Habitats Limited100-7.67 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Novateor Research Laboratories Ltd?

Novateor Research Laboratories Ltd (542771) has a market capitalisation of Rs 22.7 Cr. at the 2026-09-28 close.

What is the P/E ratio of Novateor Research Laboratories Ltd?

Novateor Research Laboratories Ltd trades at a P/E of 227 on trailing twelve-month profit, at the 2026-09-28 close.

What were Novateor Research Laboratories Ltd's latest quarterly results?

In the Mar 2026 quarter, Novateor Research Laboratories Ltd sales was Rs 1 Cr (+60.0% vs Mar 2024) and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03